Gene · 7538
ZFP36: ZFP36 zinc finger CCCH-type
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. ZFP36: ZFP36 zinc finger CCCH-type. Genes, record 7538. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/7538
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P26651 | mRNA decay activator protein ZFP36 | 326 | 1 | Ensembl, GeneID, HGNC |
Source UniProt
Patents42
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 70595 | P26651 | Espacenet |
| EP 4641202 A2 | 2025-10-29 | 9186 | P26651 | Espacenet |
| US 12295955 B2 | 2025-05-13 | 1 | P26651 | Espacenet |
| EP 4519435 A2 | 2025-03-12 | 32 | P26651 | Espacenet |
| KR 1020250017231 A | 2025-02-04 | 9186 | P26651 | Espacenet |
| US 11648251 B2 | 2023-05-16 | 1 | P26651 | Espacenet |
| KR 1020220079459 A | 2022-06-13 | 2 | P26651 | Espacenet |
| JP 2019054813 A | 2019-04-11 | 251030 | P26651 | Espacenet |
| JP 2017121241 A | 2017-07-13 | 251030 | P26651 | Espacenet |
| US 9567627 B2 | 2017-02-14 | 2 | P26651 | Espacenet |
1 to 10 of 42
See all 42 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,740
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | ZFP36 papers | Newest fiscal year |
|---|---|---|---|
| ZIAES090080 | TTP and related proteins in the regulation of gene expression | 88 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 13 | 2025 |
| ZIAAG000511 | Post-transcriptional control of Proliferation, Stress Response & Carcinogenesis | 11 | 2025 |
| ZIAAG000393 | Influence of Post-transcriptional Gene Regulation on Cell Senescence and Aging | 9 | 2025 |
| K12HD000849 | Reproductive Scientist Development Program | 5 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 5 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 4 | 2025 |
| P30CA076292 | Moffitt Cancer Center Support Grant | 4 | 2025 |
| P30CA091842 | Cancer Center Support Grant | 4 | 2025 |
| P40OD010440 | Caenorhabditis Genetics Center | 4 | 2025 |
1 to 10 of 1,740Source NIH's project files
See all 1,740 nih grantsPapers2,987
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| High ZFP36 Family Expression in Exhausted T Cells Is Associated With Impaired Antitumor Effector Function. | Cancer Sci | 2026 | 42808336 | PubTator, text mining | PubMed |
| Stress granules and RNA-binding proteins in cellular senescence: a modular perspective on stress adaptation and inflammation. | Mol Biol Rep | 2026 | 42789125 | PubTator, text mining | PubMed |
| Integrative analysis of cadmium exposure and osteoarthritis: from population evidence to molecular mechanisms. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | 42778761 | PubTator, text mining | PubMed |
| ZFP36 Family Proteins as Critical Regulators of Inflammation, Immune Cell Development, and Antiviral Responses. | Vaccines (Basel) | 2026 | 42646675 | PubTator, text mining | PubMed |
| Decoding the hypoxic injury landscape and hypoxic risk model construction in diabetic kidney disease: a multi-omics study. | Front Bioinform | 2026 | 42621048 | PubTator, text mining | PubMed |
| Selective decay of interferon mRNAs controls antiviral immunity and innate memory. | Mol Cell | 2026 | 42600621 | PubTator, text mining | PubMed |
| Functional interplay between TTP/ZFP36 and HuR/ELAVL1 in cancer: a post-transcriptional regulatory network. | Front Oncol | 2026 | 42548687 | PubTator, text mining | PubMed |
| Lymphatic therapies open the valve in Marfan syndrome. | J Clin Invest | 2026 | 42544580 | PubTator, text mining | PubMed |
| The ZFP36 Family as Post-Transcriptional Regulators in Physiology and Disease. | Int J Mol Sci | 2026 | 42511720 | PubTator, text mining | PubMed |
| The ZFP36 Family as a Post-Transcriptional Immune Checkpoint in Immunity and Disease: Molecular Mechanisms and Functional Implications. | Biomolecules | 2026 | 42509816 | PubTator, text mining | PubMed |
1 to 10 of 2,987
See all 2,987 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/7538
GET https://conductscience.org/api/genes/v1/7538/patents?page=2